PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 189 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2014. The put-call ratio across all filers is 1.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $259,000 | -52.9% | 3,300 | -54.8% | 0.22% | -54.1% |
| Q3 2015 | $550,000 | -30.7% | 7,300 | +7.4% | 0.48% | -22.8% |
| Q2 2015 | $794,000 | -50.6% | 6,800 | 0.0% | 0.62% | -52.8% |
| Q1 2015 | $1,606,000 | +26.7% | 6,800 | +1.5% | 1.32% | +22.4% |
| Q4 2014 | $1,268,000 | -20.7% | 6,700 | 0.0% | 1.08% | -21.5% |
| Q3 2014 | $1,598,000 | +657.3% | 6,700 | +109.4% | 1.38% | +690.2% |
| Q2 2014 | $211,000 | -36.6% | 3,200 | 0.0% | 0.17% | -43.7% |
| Q1 2014 | $333,000 | +0.6% | 3,200 | 0.0% | 0.31% | +40.5% |
| Q4 2013 | $331,000 | – | 3,200 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |